You are here

Gilead says additional data on remdesivir shows improved Covid-19 clinical recovery

tl-remdesivir-100720.jpg
Gilead Sciences said on Friday additional data from a late-stage study showed its antiviral remdesivir significantly improved clinical recovery and reduced the risk of death in Covid-19 patients.

[BENGALURU] Gilead Sciences said on Friday additional data from a late-stage study showed its antiviral remdesivir significantly improved clinical recovery and reduced the risk of death in Covid-19 patients.

The company said the finding requires confirmation in prospective clinical trials...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes